vs

Side-by-side financial comparison of MARCUS CORP (MCS) and Tempus AI, Inc. (TEM). Click either name above to swap in a different company.

Tempus AI, Inc. is the larger business by last-quarter revenue ($367.2M vs $193.5M, roughly 1.9× MARCUS CORP). On growth, Tempus AI, Inc. posted the faster year-over-year revenue change (83.0% vs 2.8%). MARCUS CORP produced more free cash flow last quarter ($26.4M vs $-41.5M). Over the past eight quarters, Tempus AI, Inc.'s revenue compounded faster (58.7% CAGR vs 18.2%).

Marcus & Millichap, Inc. is an American company that provides real estate brokerage, mortgage brokerage, research, and advisory services in the U.S. and Canada in the field of commercial property. It popularized the practice of listing properties exclusively with one brokerage firm. The company has over 1,800 employees in more than 80 offices across the U.S. and Canada.

Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."

MCS vs TEM — Head-to-Head

Bigger by revenue
TEM
TEM
1.9× larger
TEM
$367.2M
$193.5M
MCS
Growing faster (revenue YoY)
TEM
TEM
+80.2% gap
TEM
83.0%
2.8%
MCS
More free cash flow
MCS
MCS
$67.9M more FCF
MCS
$26.4M
$-41.5M
TEM
Faster 2-yr revenue CAGR
TEM
TEM
Annualised
TEM
58.7%
18.2%
MCS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MCS
MCS
TEM
TEM
Revenue
$193.5M
$367.2M
Net Profit
$-54.2M
Gross Margin
Operating Margin
0.9%
-16.7%
Net Margin
-14.8%
Revenue YoY
2.8%
83.0%
Net Profit YoY
-316.2%
EPS (diluted)
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCS
MCS
TEM
TEM
Q4 25
$193.5M
$367.2M
Q3 25
$210.2M
$334.2M
Q2 25
$206.0M
$314.6M
Q1 25
$148.8M
$255.7M
Q4 24
$188.3M
$200.7M
Q3 24
$232.7M
$180.9M
Q2 24
$176.0M
$166.0M
Q1 24
$138.5M
$145.8M
Net Profit
MCS
MCS
TEM
TEM
Q4 25
$-54.2M
Q3 25
$16.2M
$-80.0M
Q2 25
$7.3M
$-42.8M
Q1 25
$-16.8M
$-68.0M
Q4 24
$986.0K
$-13.0M
Q3 24
$23.3M
$-75.8M
Q2 24
$-20.2M
$-552.2M
Q1 24
$-11.9M
$-64.7M
Operating Margin
MCS
MCS
TEM
TEM
Q4 25
0.9%
-16.7%
Q3 25
10.8%
-18.3%
Q2 25
6.3%
-19.6%
Q1 25
-13.7%
-26.9%
Q4 24
-1.2%
-25.3%
Q3 24
14.1%
-29.6%
Q2 24
1.3%
-321.4%
Q1 24
-12.0%
-36.5%
Net Margin
MCS
MCS
TEM
TEM
Q4 25
-14.8%
Q3 25
7.7%
-23.9%
Q2 25
3.6%
-13.6%
Q1 25
-11.3%
-26.6%
Q4 24
0.5%
-6.5%
Q3 24
10.0%
-41.9%
Q2 24
-11.5%
-332.7%
Q1 24
-8.6%
-44.4%
EPS (diluted)
MCS
MCS
TEM
TEM
Q4 25
$-0.30
Q3 25
$-0.46
Q2 25
$-0.25
Q1 25
$-0.40
Q4 24
$2.56
Q3 24
$-0.46
Q2 24
$-6.86
Q1 24
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCS
MCS
TEM
TEM
Cash + ST InvestmentsLiquidity on hand
$23.4M
$604.8M
Total DebtLower is stronger
$159.0M
Stockholders' EquityBook value
$457.4M
$491.3M
Total Assets
$1.0B
$2.3B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCS
MCS
TEM
TEM
Q4 25
$23.4M
$604.8M
Q3 25
$7.4M
$655.9M
Q2 25
$14.9M
$186.3M
Q1 25
$11.9M
$151.6M
Q4 24
$40.8M
$341.0M
Q3 24
$28.4M
$388.0M
Q2 24
$32.8M
$478.8M
Q1 24
$17.3M
$79.9M
Total Debt
MCS
MCS
TEM
TEM
Q4 25
$159.0M
Q3 25
$162.0M
Q2 25
$179.9M
Q1 25
$198.9M
Q4 24
$159.1M
Q3 24
$173.1M
Q2 24
$175.7M
Q1 24
$169.8M
Stockholders' Equity
MCS
MCS
TEM
TEM
Q4 25
$457.4M
$491.3M
Q3 25
$454.3M
$507.8M
Q2 25
$448.4M
$309.6M
Q1 25
$441.8M
$326.2M
Q4 24
$464.9M
$56.3M
Q3 24
$462.3M
$53.7M
Q2 24
$449.4M
$98.3M
Q1 24
$459.3M
$-1.5B
Total Assets
MCS
MCS
TEM
TEM
Q4 25
$1.0B
$2.3B
Q3 25
$1.0B
$2.3B
Q2 25
$1.0B
$1.6B
Q1 25
$1.0B
$1.5B
Q4 24
$1.0B
$926.1M
Q3 24
$1.0B
$971.7M
Q2 24
$1.1B
$864.6M
Q1 24
$1.0B
Debt / Equity
MCS
MCS
TEM
TEM
Q4 25
0.35×
Q3 25
0.36×
Q2 25
0.40×
Q1 25
0.45×
Q4 24
0.34×
Q3 24
0.37×
Q2 24
0.39×
Q1 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCS
MCS
TEM
TEM
Operating Cash FlowLast quarter
$48.8M
$-36.8M
Free Cash FlowOCF − Capex
$26.4M
$-41.5M
FCF MarginFCF / Revenue
13.6%
-11.3%
Capex IntensityCapex / Revenue
11.6%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$989.0K
$-239.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCS
MCS
TEM
TEM
Q4 25
$48.8M
$-36.8M
Q3 25
$39.1M
$-119.8M
Q2 25
$31.6M
$44.2M
Q1 25
$-35.3M
$-105.6M
Q4 24
$52.6M
Q3 24
$30.5M
$48.7M
Q2 24
$36.0M
$-97.1M
Q1 24
$-15.1M
$-101.4M
Free Cash Flow
MCS
MCS
TEM
TEM
Q4 25
$26.4M
$-41.5M
Q3 25
$18.2M
$-126.5M
Q2 25
$14.7M
$36.6M
Q1 25
$-58.3M
$-107.7M
Q4 24
$27.1M
Q3 24
$12.0M
$48.6M
Q2 24
$16.1M
$-105.1M
Q1 24
$-30.5M
$-107.5M
FCF Margin
MCS
MCS
TEM
TEM
Q4 25
13.6%
-11.3%
Q3 25
8.7%
-37.9%
Q2 25
7.1%
11.6%
Q1 25
-39.2%
-42.1%
Q4 24
14.4%
Q3 24
5.2%
26.9%
Q2 24
9.2%
-63.3%
Q1 24
-22.0%
-73.7%
Capex Intensity
MCS
MCS
TEM
TEM
Q4 25
11.6%
1.3%
Q3 25
9.9%
2.0%
Q2 25
8.2%
2.4%
Q1 25
15.5%
0.8%
Q4 24
13.5%
Q3 24
7.9%
0.0%
Q2 24
11.3%
4.8%
Q1 24
11.1%
4.2%
Cash Conversion
MCS
MCS
TEM
TEM
Q4 25
Q3 25
2.41×
Q2 25
4.32×
Q1 25
Q4 24
53.31×
Q3 24
1.31×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MCS
MCS

Theatres$123.1M64%
Concessions$51.0M26%
Food And Beverage$21.2M11%

TEM
TEM

Segment breakdown not available.

Related Comparisons